CDKN2B-AS1 and melanoma: In 2007, Eric et al. [8] first discovered an antisense non-coding RNA at the INK4 locus in human whole blood leucocytes and lymphoblastoid cell lines in a genetic study of the melanoma–neural tumour syndrome family, named ANRIL (antisense non-coding RNA in the INK4 locus, ANRIL).